Truncation of the TAR DNA-binding protein 43 is not a prerequisite for cytoplasmic relocalization, and is suppressed by caspase inhibition and by introduction of the A90V sequence variant

PloS One
Heike J WobstStephen J Moss

Abstract

The RNA-binding and -processing protein TAR DNA-binding protein 43 (TDP-43) is heavily linked to the underlying causes and pathology of neurodegenerative diseases such as amyotrophic lateral sclerosis and frontotemporal lobar degeneration. In these diseases, TDP-43 is mislocalized, hyperphosphorylated, ubiquitinated, aggregated and cleaved. The importance of TDP-43 cleavage in the disease pathogenesis is still poorly understood. Here we detail the use of D-sorbitol as an exogenous stressor that causes TDP-43 cleavage in HeLa cells, resulting in a 35 kDa truncated product that accumulates in the cytoplasm within one hour of treatment. We confirm that the formation of this 35 kDa cleavage product is mediated by the activation of caspases. Inhibition of caspases blocks the cleavage of TDP-43, but does not prevent the accumulation of full-length protein in the cytoplasm. Using D-sorbitol as a stressor and caspase activator, we also demonstrate that the A90V variant of TDP-43, which lies adjacent to the caspase cleavage site within the nuclear localization sequence of TDP-43, confers partial resistance against caspase-mediated generation of the 35 kDa cleavage product.

References

Nov 2, 1999·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·L GhibelliM R Ciriolo
Nov 22, 2000·The Journal of Cell Biology·L Faleiro, Y Lazebnik
Dec 4, 2003·The International Journal of Biochemistry & Cell Biology·Yanan YangJianguo Song
Dec 6, 2003·The EMBO Journal·Haruhisa InoueRyosuke Takahashi
Nov 9, 2004·Nature·Richard I GregoryRamin Shiekhattar
May 30, 2006·Developmental Biology·Kshitish K AcharyaPrabhakara P Reddi
May 8, 2007·Molecular and Cellular Neurosciences·Michael J StrongChristen Shoesmith
Jun 27, 2007·The American Journal of Pathology·Nigel J CairnsIan R A Mackenzie
Sep 1, 2007·Molecular Biology of the Cell·Joshua B Kelley, Bryce M Paschal
Sep 28, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yong-Jie ZhangLeonard Petrucelli
Dec 20, 2007·Journal of Neurochemistry·I-Fan WangC-K James Shen
Feb 29, 2008·Proceedings of the National Academy of Sciences of the United States of America·Youhna M AyalaFrancisco E Baralle
Mar 1, 2008·Science·Jemeen SreedharanChristopher E Shaw
May 29, 2008·FEBS Letters·Matthew J WintonVirginia M-Y Lee
Sep 20, 2008·PLoS Genetics·Nicola J RutherfordRosa Rademakers
Jan 24, 2009·The Journal of Biological Chemistry·Lionel M IgazVirginia M-Y Lee
Apr 23, 2009·Proceedings of the National Academy of Sciences of the United States of America·Yong-Jie ZhangLeonard Petrucelli
Jun 12, 2009·Human Molecular Genetics·Takashi NonakaMasato Hasegawa
Sep 22, 2009·Journal of Neurochemistry·Claudia ColombritaAntonia Ratti
Nov 6, 2009·The Journal of Biological Chemistry·Yoshinori NishimotoNorihiro Suzuki
Apr 2, 2010·Journal of Cell Science·Mimi CushmanJames Shorter
Apr 29, 2010·The FEBS Journal·Emanuele BurattiFrancisco Baralle
May 18, 2010·Nanomedicine : Nanotechnology, Biology, and Medicine·Armin KramerVictor Shahin
Nov 6, 2010·The Journal of Biological Chemistry·Chantelle F SephtonGang Yu
Jan 25, 2011·Human Molecular Genetics·Karli K McDonaldChristine Vande Velde
Mar 2, 2011·Nature Neuroscience·James R TollerveyJernej Ule
Mar 2, 2011·Nature Neuroscience·Magdalini PolymenidouDon W Cleveland
Nov 4, 2011·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Joanna Iłżecka
Feb 11, 2012·Proceedings of the National Academy of Sciences of the United States of America·Yukio Kawahara, Ai Mieda-Sato
Mar 30, 2012·Journal of Human Genetics·Huei-Hsin ChiangCaroline Graff
Jun 30, 2012·Nature Methods·Johannes SchindelinAlbert Cardona

❮ Previous
Next ❯

Citations

May 30, 2020·British Journal of Pharmacology·Emanuele Buratti
Apr 30, 2019·Frontiers in Neuroscience·Britt A Berning, Adam K Walker
Jul 23, 2020·Virologica Sinica·Xiaoman WoWenran Zhao
Feb 13, 2018·Expert Opinion on Therapeutic Targets·Emanuele Buratti
Mar 7, 2019·Frontiers in Molecular Neuroscience·Archana PrasadBasant K Patel
Jun 4, 2021·Neurochemistry International·Joshua M MarcusShaida A Andrabi

❮ Previous
Next ❯

Methods Mentioned

BETA
ubiquitination

Software Mentioned

NIS Elements
GENEWIZ
Fiji

Related Concepts

Related Feeds

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.